Overlapping of Primary Biliary Cirrhosis and Small Duct Primary Sclerosing Cholangitis: First Case Report
暂无分享,去创建一个
L. Andrade | A. Dellavance | V. Lanzoni | Antonio Eduardo Benedito Silva | M. L. Ferraz | P. Oliveira | Elze Maria Gomes Oliveira | Vitória Becker | L. Andrade
[1] Lu Lun-ge,et al. Overlap syndromes:the international autoimmune hepatitis group(IAIHG) position statement on a controversial issue , 2011 .
[2] Gideon M. Hirschfield,et al. Primary Biliary Cirrhosis , 2010 .
[3] T. Karlsen,et al. Update on primary sclerosing cholangitis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[4] A. Czaja. Autoantibodies as Prognostic Markers in Autoimmune Liver Disease , 2010, Digestive Diseases and Sciences.
[5] A. Jeevagan. Overlap of primary biliary cirrhosis and primary sclerosing cholangitis – a rare coincidence or a new syndrome , 2010, International journal of general medicine.
[6] G. Gores,et al. Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.
[7] P. Milkiewicz,et al. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[8] M. Kaplan,et al. Primary biliary cirrhosis , 1998, Hepatology.
[9] Paulo Luiz Carvalho Francescantônio,et al. Third Brazilian Consensus for autoantibodies screening in HEp-2 cells (ANA). Recommendations for standardization of autoantibodies screening trial in HEp-2 cells, quality control and clinical associations , 2009 .
[10] T. Karlsen,et al. Autoantibodies in primary sclerosing cholangitis. , 2008, World journal of gastroenterology.
[11] U. Beuers,et al. Overlap syndromes among autoimmune liver diseases. , 2008, World journal of gastroenterology.
[12] K. Boberg,et al. The natural history of small-duct primary sclerosing cholangitis. , 2008, Gastroenterology.
[13] J. Talwalkar,et al. Overlap of Autoimmune Hepatitis and Primary Biliary Cirrhosis: Long-Term Outcomes , 2007, The American Journal of Gastroenterology.
[14] P. Invernizzi,et al. Interpreting serological tests in diagnosing autoimmune liver diseases. , 2007, Seminars in liver disease.
[15] O. Chazouilleres,et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. , 2006, Journal of hepatology.
[16] J. Kingham,et al. Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective , 2005, European journal of gastroenterology & hepatology.
[17] R. Chapman,et al. Review article: current management of primary sclerosing cholangitis , 2005, Alimentary pharmacology & therapeutics.
[18] M. Manns,et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. , 2004, Journal of hepatology.
[19] T. Therneau,et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. , 2003, Gastroenterology.
[20] R. Poupon. Autoimmune overlapping syndromes. , 2003, Clinics in liver disease.
[21] Howard J Worman,et al. Antinuclear antibodies specific for primary biliary cirrhosis. , 2003, Autoimmunity reviews.
[22] G. Bianchi,et al. Characterization and Clinical Impact of Antinuclear Antibodies in Primary Biliary Cirrhosis , 2003, American Journal of Gastroenterology.
[23] K. Boberg,et al. Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis , 2002, Gut.
[24] J. Heathcote. Variant syndromes of autoimmune hepatitis. , 2002, Clinics in liver disease.
[25] K. Lindor,et al. Small‐duct primary sclerosing cholangitis: A long‐term follow‐up study , 2002, Hepatology.
[26] M. Lenzi,et al. The Hepatitic/Cholestatic "Overlap" Syndrome: An Italian Experience , 2002, Autoimmunity.
[27] F. Cassani,et al. Autoimmune serology of primary sclerosing cholangitis. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[28] D. Vergani,et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study , 2001, Hepatology.
[29] M. Swain,et al. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases. , 2001, Digestive diseases and sciences.
[30] K. Lindor,et al. Serum autoantibodies in patients with primary sclerosing cholangitis. , 2000, Journal of hepatology.
[31] A. Czaja. Frequency and nature of the variant syndromes of autoimmune liver disease , 1998, Hepatology.
[32] O. Chazouilleres,et al. Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy , 1998, Hepatology.
[33] K. Lazaridis,et al. Primary biliary cirrhosis , 1998, Springer Netherlands.
[34] T. Sternsdorf,et al. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis , 1997, Hepatology.
[35] K. Boberg,et al. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis , 1996, Hepatology.
[36] R. Wiesner,et al. Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. , 1988, Journal of hepatology.
[37] R. Wiesner,et al. Intrahepatic cholangiectases and large‐duct obliteration in primary sclerosing cholangitis , 1986, Hepatology.
[38] L. Seeff,et al. Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome. , 1984, Archives of pathology & laboratory medicine.
[39] R. Chapman,et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.
[40] W. Ewig. [Diseases of the bile ducts]. , 1961, Hippokrates.